EUVIMEDSkopri EUVIMED
Crossref

Diosmin Alleviates Pain via Mechanisms Involving Acetylcholinesterase and TRPV1 Inhibition: An In Silico and In Vivo Study

Aya Y Al-Kabariti, Belal O Al-Najjar, Mohammad Alsalem, Manal A Abbas iD

Basic & Clinical Pharmacology & Toxicology · 2026

DOI: 10.1111/bcpt.70199 ↗

At a glance

Journal article in Basic & Clinical Pharmacology & Toxicology, 2026. Written by Aya Y Al-Kabariti and 3 co-authors. Institution: Department of Biopharmaceutics and Clinical Pharmacy, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan. Major MEDLINE topics: TRPV Cation Channels, Diosmin, Acetylcholinesterase, Analgesics. Cited 2 times so far (Crossref); 44 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

Diosmin, a flavonoid glycoside with reported anti‐inflammatory effects, was evaluated for its potential analgesic activity using in vivo and in silico studies.

Methods

The antinociceptive effect of diosmin was evaluated in mice using capsaicin‐ and formalin‐induced paw‐licking tests as well as hot plate and tail flick assays. Target prediction using Similarity Ensemble Approach (SEA) and molecular docking were conducted to validate diosmin's interaction with Transient Receptor Potential Vanilloid 1 (TRPV1) and acetylcholinesterase (AChE) in silico.

Findings

Diosmin (60 and 30 mg/kg) significantly reduced pain behaviour by 90.8% and 83.2%, respectively, in the capsaicin‐induced paw‐licking test, while BCTC, a TRPV1 antagonist, significantly blocked diosmin action. In the formalin test, atropine significantly blocked the action of diosmin at the early phase. Diosmin at 60 mg/kg increased hot plate latency by 104.8%. In the tail flick test, diosmin at 60 and 30 mg/kg increased latency by 103.7% and 90.6%, respectively, indicating central analgesic effects. No significant alterations in body temperature were observed. Docking studies confirmed diosmin's favourable binding to the active site of AChE with a binding energy of −9.77 kcal/mol. Diosmin engages the TRPV1 vanilloid pocket mainly through hydrophobic interactions.

Conclusion

Diosmin exerts central and peripheral antinociceptive effects mediated, at least partially, through TRPV1 antagonism and cholinergic pathways.

Subjects

MeSH terms (MEDLINE)

TRPV Cation ChannelsDiosminAcetylcholinesteraseAnalgesicsCholinesterase InhibitorsPainAnimalsMolecular Docking SimulationMiceMalePain MeasurementCapsaicinComputer Simulation

Author keywords

TRPV1 receptoracetylcholinesterasediosminmolecular docking simulationpain

Substances

TRPV Cation ChannelsDiosminAcetylcholinesteraseAnalgesicsTRPV1 protein, mouseCholinesterase InhibitorsCapsaicin

Authors and institutions

  • Department of Biopharmaceutics and Clinical Pharmacy, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan.
  • Pharmacological and Diagnostic Research Center, Al-Ahliyya Amman University, Amman, Jordan.
  • Department of Pharmaceutical Sciences, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan.
  • Department of Anatomy and Histology, School of Medicine, The University of Jordan, Amman, Jordan.
  • Department of Medical Laboratory Sciences, Faculty of Allied Medical Sciences, Al-Ahliyya Amman University, Amman, Jordan.

ORCID profiles: Manal A Abbas

Cite

APA

Al-Kabariti, A. Y., Al-Najjar, B. O., Alsalem, M., & Abbas, M. A. (2026). Diosmin Alleviates Pain via Mechanisms Involving Acetylcholinesterase and TRPV1 Inhibition: An In Silico and In Vivo Study. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.70199

Vancouver

Al-Kabariti AY, Al-Najjar BO, Alsalem M, Abbas MA. Diosmin Alleviates Pain via Mechanisms Involving Acetylcholinesterase and TRPV1 Inhibition: An In Silico and In Vivo Study. Basic & Clinical Pharmacology & Toxicology. 2026. doi:10.1111/bcpt.70199

BibTeX
@article{AlKabariti2026,
  author = {Al-Kabariti, Aya Y and Al-Najjar, Belal O and Alsalem, Mohammad and Abbas, Manal A},
  title = {Diosmin Alleviates Pain via Mechanisms Involving Acetylcholinesterase and TRPV1 Inhibition: An In Silico and In Vivo Study},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2026},
  doi = {10.1111/bcpt.70199}
}
Start for free →